Jacquet, Jeanne-Marie

van Damme, Pierre

van Herck, Koen

Abstract: Long-term persistence of vaccine-induced immune response in adults was assessed annually for 15 years following primary immunization with a two-dose inactivated hepatitis A vaccine. In 1992, 119 and 194 subjects aged 1740 years and na\uefve for hepatitis A virus (HAV) were enrolled in two studies to receive 1,440 ELISA units (El.U) of inactivated hepatitis A vaccine (Havrix, GlaxoSmithKline Biologicals, Belgium) according to a standard 0, 6 or an extended 0, 12 months schedule, respectively. Serum samples were taken 1 month after the second vaccine dose and every consecutive year up to 15 years after primary vaccination for measurement of anti-HAV antibody concentrations (NCT00291876 and NCT00289757). At year 15, 100% (48/48) and 97.3% (108/111) of subjects vaccinated at 0, 6 or 0, 12 months remained seropositive for anti-HAV antibodies, with geometric mean concentrations (GMCs) of 289.2 and 367.4\u2009mIU/ml, respectively. An additional dose of HAV vaccine (1,440\u2009El.U) was administered to the six subjects who had become seronegative for anti-HAV antibodies since year 11. All subjects mounted a humoral immune response to the additional HAV challenge dose, although post-challenge anti-HAV antibody levels remained low in one subject. These studies represent the longest annual follow-up of hepatitis A vaccine in healthy adults. The immune response induced by two doses of this inactivated HAV vaccine was shown to persist for at least 15 years. No difference in long-term antibody persistence was observed between the two primary vaccination schedules, reinforcing the potential for flexibility in the timing of the second primary vaccine dose

Institutional Repository Universiteit Antwerpen

Antibody persistence and immune memory in healthy adults following vaccination with a two-dose inactivated hepatitis A vaccine : long-term follow-up at 15 years

Antibody persistence and immune memory in healthy adults following vaccination with a two-dose inactivated hepatitis A vaccine : long-term follow-up at 15 years

Abstract

Similar works

Full text

Available Versions

Institutional Repository Universiteit Antwerpen